Introduction {#S1}
============

The polyunsaturated fatty acids (PUFAs), especially *n* − 3 fatty acids such as eicosapentaenoic acid (EPA, 20:5, *n* − 3) and docosahexaenoic acid (DHA, 22:6, *n* − 3), mainly derived from fish oil and seaweed, phytoplankton, and camelina ([@B1]), have been found to play positive roles in human health ([@B2]). A series of studies have shown the efficient function of EPA and DHA in preventing body overweight and obesity ([@B3]--[@B6]). *n* − 3 fatty acids are widely considered as a dietary supplement during pregnancy, because of the benefit to fetal neurodevelopment and infant birth weight ([@B7]). Although, overdosage of EPA and DHA is rare, it was reported that adverse effects such as the risk of bruising or bleeding caused by high intake of EPA and DHA in extreme circumstances (anticoagulants and antiplatelets treatments) were observed in several controlled human intervention studies ([@B8]). Clinical research showed that EPA and DHA supplementation during pregnancy accumulates in fetal tissues and causes a longer gestation ([@B9]). However, no study has addressed the question whether high intake of EPA and DHA affects fetal muscle development during gestation.

Skeletal muscle composes 40--50% or body weight and is an essential organ for glucose and fatty-acid utilization ([@B10]). Fetal stage is crucial for skeletal muscle development because of the limited increase in muscle fiber number after birth ([@B11]). During fetal muscle development, mesenchymal stem cells undergo myogenesis, adipogenesis, and fibrogenesis. The muscle growth in the postnatal stages occurs mainly due to the increase of the diameter and length of muscle fibers instead of muscle fiber (muscle cell) numbers. This indicates that muscle stem cells can be utilized as an *in vitro* model to study the muscle growth and development during the fetal stage. Comparing with central neuro system and cardiovascular tissue, skeletal muscle has a relatively lower priority of nutrition repartitioning which makes the development of skeletal muscle especially vulnerable to nutritional change ([@B12]). Studies in a sheep model indicated that maternal obesity induced by high-energy diet showed downregulation effect on fetal myogenesis and impaired skeletal muscle development in offspring, but increased number and size of intramuscular adipocytes in the fetus at mid- and late-gestation ([@B13]--[@B16]). Due to the metabolic importance, fetal skeletal muscle is considered as one of the target organs of lipid accumulation that induced by a high-fat or high-carbohydrate maternal diet ([@B17], [@B18]). It raises up a question whether a high-energy maternal diet rich in PUFAs similarly affects fetal muscle cell differentiation and adipose deposition during gestation.

In most eukaryotes, mitochondria are primary organelles that response for energy metabolism which derived from the breakdown of carbohydrates and fatty acids. It was reported that the *n* − 3 PUFAs could cause higher oxidation levels of mitochondrial fatty acids in the myocardium ([@B19]--[@B22]). EPA and DHA individually increase mitochondrial biosynthesis in skeletal muscle stem cells ([@B23]--[@B25]). Therefore, we hypothesize that EPA and DHA treatment on myofibroblasts (C2C12 cells) may affect the myogenesis and adipogenesis *via* metabolic changes in mitochondria.

The objective of the current study was to measure the effect of maternal EPA and DHA supplement on myotube formation and potential pathways related to adipose deposition and mitochondrial biosynthesis using myofibroblasts as *in vitro* model.

Materials and Methods {#S2}
=====================

Cell Culture {#S2-1}
------------

Murine C2C12 myoblasts (cells were kindly donated by Dr. Jamie Baum from University of Arkansas) were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum and 1U penicillin-streptomycin at 37°C in a 5% CO2 atmosphere. When cells confluency reached more than 90%, control group (CON) was induced to fuse and form myotubes by switching to the differentiation medium (DM) containing 2% horse serum and 1U penicillin-streptomycin, while 50-µM EPA and 50-µM DHA were added to DM in the fatty-acid treatment group (FA). DM with or without fatty acids was changed every 24 h for 3 days.

Hematoxylin and Eosin (H&E) Staining {#S2-2}
------------------------------------

Myotube formation is the direct observation of myogenesis. Myotube formation was observed by conducting H&E staining as described previously ([@B26]). Briefly, cells in 6-well plates (three for CON group and three for FA group) were fixed with ice-cold 100% ethanol, then froze in −20°C for 7 min. Hematoxylin stain was added to each well and stained for 5 min. Cells were rinsed with running tap water. Eosin stain was added in wells and stained for 30 s. Cells were rinsed with running tap water and rinse with phosphate-buffered saline. Cells were dried at room temperature before coverslips were mounted on the cells. Pictures were taken under a microscope (Nikon Eclipse Ts2R, Nikon, Melville, NY, USA) with the camera (Nikon DS-Fi3 digital camera system) and software (NIS-Elements BR, Nikon, Melville, NY, USA). Three pictures were randomly taken from each well, and total nine pictures for each group were analyzed for the myotube formation. The diameter and number of myotubes were measured using ImageJ software (US National Institutes of Health).

Real-Time PCR {#S2-3}
-------------

Gene expression related to myogenesis, adipogenesis, mitochondrial biosynthesis, and peroxisome biosynthesis were measured by quantitative real-time PCR. Total RNA was extracted from cells with the TRIzol reagent (Fisher, Pittsburgh, PA, USA). The concentration of total RNA was assessed by Nanodrop OneC (Thermo Scientific, Waltham, MA, USA), and quality was examined in the absorption ratio of OD~260 nm~/OD~280 nm~. The cDNA was synthesized from the RNA with iScript cDNA synthesis kit (Bio-Rad, Richmond, CA, USA). Real-time PCR was carried out by using SYBR Green Supermix (Bio-Rad, Richmond, CA, USA) on CFX Connect Real-Time PCR Detection System (Bio-Rad, Richmond, CA, USA). The oligonucleotide primers (Table [1](#T1){ref-type="table"}) used were designed with NCBI database and Primer Quest ([IDT.com](IDT.com)). Each reaction yielded amplicons from 80 to 200 bp. PCR conditions were as follows: 30 s at 95°C, 30 s at 55°C, and 40 s at 72°C for 40 cycles. After amplification, a melting curve (0.01°C/s) was used to confirm product purity, and the PCR products were electrophoresed to confirm the targeted sizes. Results are expressed relative to β-actin. Data were analyzed using the ΔΔCT method and β-actin gene was the reference gene.

###### 

List of primers.

  Primers         Accession no.   Forward sequence             Reverse sequence
  --------------- --------------- ---------------------------- ----------------------------
  MyoD            NM_010866       TCTGGAGCCCTCCTGGCACC         CGGGAAGGGGGAGAGTGGGG
  MyoG            NM_031189       GCAATGCACTGGAGTTCG           ACGATGGACGTAAGGGAGTG
  MRF4            NM_008657       GTGGACCCCTACAGCTACAAACC      TGGAAGAAAGGCGCTGAAGAC
  Pax7            NM_011039       CTCAGTGAGTTCGATTAGCCG        AGACGGTTCCCTTTGTCGC
  PMP70           NM_008991       AAGAATGGCGATGGCAAGACT        TGTGAAACGGTAAAGAGGGTGAT
  Pex2            NM_008994       TGAAGGAACCACTTAGAAATTACAGA   CCAGGGCCTTATTCAGTTCA
  Pex19           NM_023041       CAGAGTGAGATGTGTTAGGAGATG     GTGCCAAGGAGACGAAGAC
  ERRa            NM_007953       GGTGTGGCATCCTGTGAGGC         AGGCACTTGGTGAAGCGGCA
  TFAM            NM_009360       GCTTGGAAAACCAAAAAGAC         CCCAAGACTTCATTTCATT
  PGC1a           NM_008904       TCCTCTGACCCCAGAGTCAC         CTTGGTTGGCTTTATGAGGAGG
  aP2             NM_024406       CGACAGGAAGGTGAAGAGCATCATA    CATAAACTCTTGTGGAAGTCACGCCT
  C/EBPa          NM_007678       GCAAGCCAGGACTAGGAGAT         AATACTAGTACTGCCGGGCC
  C/EBPb          NM_001287738    AAGCTGAGCGACGAGTACAAGATG     TTGAACAAGTTCCGCAGGGTGCT
  PPARg           NM_001127330    GATGTCTCACAATGCCATCAG        TCAGCAGACTCTGGGTTCAG
  CPT1            NM_009948       TATAACAGGTGGTTTGACA          CAGAGGTGCCCAATGATG
  FAT             NM_001159558    CTCCTAGTAGGCGTGGGTCT         CACGGGGTCTCAACCATTCA
  Rpl7            NM_011291       GAAGCTCATCTATGAGAAGGC        AAGACGAAGGAGCTGCAGAAC
  β-actin         NM_007393       AAATCGTGCGTGACATCAAA         AAGGAAGGCTGGAAAAGAGC
  mtDNA(Ttll3)    NM_133923       CGATAAACCCCGCTCTACCT         AGCCCATTTCTTCCCATTTC
  nDNA ([@B27])                   CCTTGGGTCCTTGGCTTCGTTCCT     CTCAGCAATCAGCCGTCCAATTCCTA

Oxygen Consumption Measurement {#S2-4}
------------------------------

Mitochondrial activities and metabolic levels can be determined by conducting oxygen consumption measurement. Oxygen consumption rate (OCR) of C2C12 cells was measured in real time using a Seahorse XF24 extracellular flux analyzer (Seahorse Bioscience, North Billerica, MA, USA) ([@B28]). C2C12 cells were seeded at 3 × 10^4^ per well in 24-well XF plates. DM with or without EPA and DHA was then used to culture cells for 72 h once cells reached confluence. The cells were refreshed with non-buffered pH7.4 medium (25-mM glucose) and incubated for 1 h in a non-CO2 incubator. A Seahorse XF24 Analyzer was then used to measure the OCR.

Statistical Analyses {#S2-5}
--------------------

Differences between groups were assessed for significance by the unpaired Student's *t*-test with the assumption of equal variances, and arithmetic means ± SEM are reported. Statistical significance was considered as *P* ≤ 0.05.

Results {#S3}
=======

Myotube Formation in CON and FA Groups {#S3-1}
--------------------------------------

After induced differentiation, rod-shaped C2C12 myoblasts fused and elongated to develop into nascent myotubes. Fewer myotubes with smaller diameter were observed histochemically in FA group than in CON group (Figures [1](#F1){ref-type="fig"}A--F). The average diameter of myotubes in FA group was 38.10 ± 3.33% lower (*P* \< 0.05) than in CON group. The total myotube number in the field in FA group was 32.73 ± 16.07% lower (*P* \< 0.05) than in CON group (Figure [1](#F1){ref-type="fig"}G).

![Myotube formation of C2C12 cells in control (CON) and EPA/DHA (FA) medium. **(A--F)** H&E staining of C2C12 cells. Pictures are shown in different magnification: 100× and 200×. **(G)** The diameter and length of myotubes measured based on the H&E staining images. Data show the change of the diameter and numbers of myotubes in FA group compared with CON group. The relative changes were calculated in arbitrary units. \**P* \< 0.05; *n* = 9 pictures for each group.](fnut-05-00015-g001){#F1}

mRNA Expression of Genes Affected by FA Treatment {#S3-2}
-------------------------------------------------

To determine the effect of EPA and DHA media supplement on the growth of the cells, we conducted qPCR targeted on the genes related to myogenesis, adipogenesis, mitochondrial biogenesis, and peroxisome biogenesis. Most of the myogenesis-related genes were downregulated by FA treatment (Figure [2](#F2){ref-type="fig"}). The expressions of MRF4, MyoD, and MyoG were all decreased (44.61 ± 3.66, 30.12 ± 8.07, and 46.25 ± 1.83%, respectively, *P* \< 0.05) in FA treatment group compared with CON group. Pax7 was tended to be suppressed by FA treatment (60.31 ± 20.93%, *P* = 0.09) compared with CON group.

![The relative gene expression related to myogenesis of C2C12 cells in control (CON) and EPA/DHA (FA) medium. Data show the change of their mRNA expression in FA group compared with CON group. The relative expressions were calculated in arbitrary units. \**P* \< 0.05 and ^&^ *P* \< 0.1; *n* = 3.](fnut-05-00015-g002){#F2}

The mRNA expression of genes related to adipogenesis in C2C12 cells was increased in FA group (Figure [3](#F3){ref-type="fig"}). aP2 expression in FA group is 17.76 ± 0.80 times (*P* \< 0.05) of the expression in CON group. The expressions of c/EBPα, c/EBPb, PPARγ, CPT1b, and FAT were all higher (70.08 ± 1.04, 21.84 ± 5.35, 34.06 ± 11.33, 108.82 ± 17.47, and 9.40 ± 5.42%, respectively, *P* \< 0.05) in FA treatment group than in CON group.

![The relative gene expression related to adipogenesis of C2C12 cells in control (CON) and EPA/DHA (FA) medium. Data show the change of their mRNA expression in FA group compared with CON group. The relative expressions were calculated in arbitrary units. \**P* \< 0.05; *n* = 3.](fnut-05-00015-g003){#F3}

FA supplement suppressed gene related to mitochondrial function and biogenesis (Figure [4](#F4){ref-type="fig"}). The mRNA expression of ERRα (estrogen-related receptor alpha), TFAM (mitochondrial transcription factor A), and PGC1α (peroxisome proliferator-activated receptor gamma coactivator 1 alpha) were downregulated (25.63 ± 7.10, 22.87 ± 3.64, and 31.33 ± 8.62%, respectively, *P* \< 0.05) by FA compared with CON group. Mfn2 (mitofusin 2) was tended to be decreased (6.61 ± 3.64%, *P* = 0.09) in FA group compared with CON group. The ratio of mtDNA to nDNA was significantly lower (38.07 ± 9.68%, *P* \< 0.05) in FA-treated cells than in the CON cells.

![The relative gene expression related to mitochondrial biogenesis and function of C2C12 cells in control (CON) and EPA/DHA (FA) medium. Data show the change of their mRNA expression in FA group compared with CON group. The relative expressions were calculated in arbitrary units. \**P* \< 0.05 and ^&^ *P* \< 0.1; *n* = 3.](fnut-05-00015-g004){#F4}

Genes related to peroxisome biogenesis are also affected by FA treatment (Figure [5](#F5){ref-type="fig"}). PMP70 and Pex2 were significantly upregulated (43.27 ± 9.97 and 64.20 ± 15.97%, *P* \< 0.05) by FA, and Pex19 was tended to be promoted (33.89 ± 16.94%, *P* = 0.06) by FA. However, Pex11a and Pex5 were lower significantly and non-significantly (23.37 ± 0.4%, *P* \< 0.05 and 21.22 ± 12.53%, *P* = 0.09, respectively).

![The mRNA expression of the genes related to peroxisome biogenesis of C2C12 cells in control (CON) and EPA/DHA (FA) medium. Data show the change of their mRNA expression in FA group compared with CON group. The relative expressions were calculated in arbitrary units. \**P* \< 0.05 and ^&^ *P* \< 0.1; *n* = 3.](fnut-05-00015-g005){#F5}

Oxygen Consumption Rate {#S3-3}
-----------------------

To confirm whether the metabolism of the cells was affected by FA treatment through changed gene expression related to mitochondria and peroxisome, we measured the oxygen consumption in Seahorse system and calculated the OCR in the two groups normalized to cell number. Results showed that the maximum oxygen consumption capacity stimulated by 350-nM FCCP and inhibited by 10-µM antimycin was significantly decreased (17.79 ± 2.67%, *P* \< 0.05) by FA treatment compared with CON group with no FA in the DM (Figure [6](#F6){ref-type="fig"}).

![Metabolic profiling of C2C12 cells in in control (CON) and EPA/DHA (FA) medium. **(A)** Total oxygen consumption (reserve capacity) is significantly lower in FA group. Data show the change of oxygen consumption rates (OCR) in FA group compared with CON group. The relative change was calculated in arbitrary units. **(B)** Basal and stimulated mitochondrial OCR in cultured C2C12 cells. OCR traces are expressed as pmol O~2~ per min in C2C12 cells and normalized to cell number. Vertical dashed lines indicate the times of addition of oligomycin (2 µM), FCCP (350 nM), and antimycin A (10 µM). \**P* \< 0.05; *n* = 11.](fnut-05-00015-g006){#F6}

Discussion {#S4}
==========

Long-chain polyunsaturated fatty acids (LCPUFAs) pass through the human placenta and can be delivered to the fetus ([@B17], [@B29]). Moreover, they are present in the breast milk to affect postnatal growth and development ([@B30]). Imbalance in PUFA intake, including maternal malnutrition or overnutrition, during fetal development, changes the fatty-acid deposition in the cell membrane as phospholipids and causes implication for cell structure and function ([@B17]). Insufficient maternal nutrient intake has been widely studied. The lower level of maternal *n* − 3 fatty acids is related to higher body and abdominal fat mass in childhood ([@B31]). On the other hand, maternal obesity, overeating, and overnutrition also increase the risk of metabolic disorders in the fetus and subsequently induce postnatal obesity ([@B32], [@B33]). It was reported that excessive *n* − 3 fatty-acid intake resulted in growth deficiencies such as slower neural transmission times and postnatal growth restriction ([@B34]). Animal growth is contributed to bone formation, muscle building, and fat tissue deposition. During later gestation and early postnatal stage, muscle and adipose tissue growth are highly affected by maternal nutrition level. This study tried to discover the effect of *n* − 3 fatty acids on the myoblasts growth in gene expression level. Based on previous studies of EPA and DHA in cell culture study, EPA and DHA are toxic for C2C12 cells when the concentration is \>50 µM ([@B35]). Therefore, 50 µM was selected in the current study for EPA and DHA as a high concentration without apparent toxicity to C2C12 cells.

During myogenic differentiation, we found that several vital myogenic genes were significantly downregulated in FA-treated group, such as MRF4, MyoD, and MyoG. MRF4, also known as myogenic factor 6 (MYF6), plays a role the in myotube maturation. MyoD and MyoG, as well as MRF4, belong to myogenic regulatory factors, but their functions are slightly different. MyoD is one of the earliest myogenic markers. MyoG is a crucial gene that regulates the secondary muscle fibers maturation ([@B36]). Pax 7 is critical for regulating the differentiation of satellite cells ([@B37]). Once myoblasts start myogenic differentiation, Pax7 usually does not express. In our study, the Pax7 expression was lower in FA group, although the average decreasing was \>60%, the variation of the response is enormous, which indicated the initiation of myogenic differentiation induced by FA was not constant. The results of this study showed that the PUFA treatment inhibits myotube formation and eventually arrests the development of myofibers. These adverse effects were confirmed later in H&E staining by showing fewer and smaller myotubes formed in FA group. However, previous study showed that EPA alone promotes skeletal muscle protein accretion with the [L]{.smallcaps}-leucine supplement, but not DHA ([@B38]). Leucine is one of the branched-chain amino acids that are highly effective to accelerate skeletal muscle protein synthesis. It may have additional effect on EPA to elevate muscle growth. Our results may indicate that without [L]{.smallcaps}-leucine, the effect of EPA on muscle growth might be negative. Also, our data showed that the combination of EPA and DHA might be antagonistic to muscle growth.

Most of the essential genes related to adipogenesis, such as aP2, C/EBPα, C/EBPb, PPARγ, CPT1b, and FAT, were upregulated in FA group. aP2 is also called fatty-acid binding protein 4, for its function of carrying protein for fatty acids to regulate lipid metabolism and mostly expressed in adipocytes. In this study, aP2 gene expression was dramatically stimulated by EPA and DHA treatment, which was 1,700% of the expression in CON group. *n* − 3 fatty acids usually have a high degree of unsaturation, result into the quickly processed fatty-acid oxidation, and stimulate PPARs ([@B39]). PPAR isoforms participate in lipid homeostasis and glucose regulation. PPARs target the specific genes, for example, aP2, which contain specific DNA regions called peroxisome proliferator hormone response elements ([@B40]). Fatty infiltration in skeletal muscle is accompanying with aging in human ([@B41]). These results showed that potentially upregulated adipogenesis in C2C12 cell culture could be triggered by EPA and DHA treatment. Our findings were consisted with an *in vivo* study, which showed upregulated adipogenesis in pig suppled with DHA ([@B42]). The upregulated adipogenesis and the decreased myogenic gene expression may indicate that overdosing EPA and DHA is associated with muscle aging. CEBPs are critical for the regulation of genes related to immune and inflammatory responses. However, IL-6 and TNF-a gene expressions are similar between CON and FA group.

As the "powerhouse" of the cell, mitochondria break fuel molecules and provide energy to the cell in the formation of ATP. The mitochondrial oxidative phosphorylation system is considered as the primary source for energy production, which relies on the structure of mitochondrial inner membrane ([@B43]). PGC1 family is a group of transcriptional coactivators regulates cellular energy metabolic pathways and mitochondrial biosynthesis ([@B44], [@B45]). ERRα and its down-streaming target gene Mfn2 are key genes that regulate mitochondrial fusion and metabolism ([@B46]). TFAM is an essential activator of mitochondrial genome replication. The mRNA expression data of this study showed that PUFA supplement in DM during myogenesis inhibits the expression of the key genes of mitochondrial metabolism and biosynthesis. The decreasing of the mitochondrial biosynthesis was confirmed by measuring the ratio of mtDNA/nDNA. The ratio of mtDNA/nDNA is often used an estimate for the mtDNA copy number per cell ([@B47]). It is a high-level indicator if mitochondrial biogenesis as the mitochondrial genome encodes most of the enzymatic subunits of the oxidative phosphorylation system. The decreased mitochondrial metabolism was supported by testing the respiration of the cells, which showed the PUFA-treated cells consumed less oxygen which indicated less-mitochondrial metabolism. Harmed mitochondrial dynamics and biosynthesis negatively affect the regulation of energy expenditure which leads to obesity and diabetes ([@B48]), which implies that overdosing EPA and DHA during gestation may have a long-term effect on offspring metabolic disorder.

Peroxisomes are found of playing a significant role in breaking down very long chain fatty acid \[greater than C22, such as DHA which is 22:6 (*n* = 3)\] through beta-oxidation, but is not coupled to ATP synthesis ([@B49]). Peroxisomal membrane proteins (PMPs), which are encoded by peroxisomal biogenesis genes (PEXs), are involved in peroxisome biogenesis ([@B50]). Among them, PMP70 and Pex19 are considered as the critical proteins in peroxisomal proliferation and biogenesis ([@B51], [@B52]). The altered expression of PEXs in this study indicated that PUFAs affect peroxisomal biogenesis. The high-potential electrons produced by beta-oxidation in peroxisomes are transferred to yield H2O2, which generates heat and contributes to the accumulation of reactive oxygen species (ROS). The mitochondrial antioxidant system removes ROS production and inhibits ROS production. The lower metabolism of mitochondria induced by EPA and DHA may enhance the oxidative stress in myoblasts differentiation and cause structural and functional muscle abnormalities ([@B53]). This may be an explanation of downregulated myogenic gene expression and smaller and fewer myotube formation.

Conclusion {#S5}
==========

This study demonstrated the effects of EPA and DHA supplement in C2C12 myogenic differentiation. The key gene expression in myogenesis, adipogenesis, mitochondrial, and peroxisomal biosynthesis in C2C12 cells during myogenic differentiation is affected by EPA and DHA. The myotube formation is inhibited while PUFA treatment upregulates adipogenic gene expression. Strengthened peroxisomal biosynthesis and weakened mitochondrial metabolism and biosynthesis imply that the overdosed PUFAs change energy expenditure, and may cause ROS stress that negatively regulates myogenesis. These indicate that the maternal overdosage of EPA and DHA may influence fetal muscle development, increase intramuscular adipose tissue deposition in offspring, and have a long-term effect on the development of metabolic disease such as obesity and diabetes in adult offspring.
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